Production Featured Articles
-
Small Joint Implants: A New Era With Medureon™ Bionate
5/27/2026
Advances in biomaterials address challenges of small joint implants, improving durability, flexibility, and biocompatibility to reduce wear, enhance motion, and support long‑term patient outcomes.
-
Simulating PUPSIT Or Gas Purges In Bacterial Challenge Tests
5/22/2026
Managing PUPSIT‑related risks is a critical part of contamination control. Learn how bacterial retention studies, wetting fluids, and downstream practices influence sterility assurance.
-
Product-Wet Integrity Testing: Risk-Based Strategies
5/22/2026
When standard water‑based integrity testing falls short, product‑wet approaches can offer a more representative alternative. Learn how risk‑based strategies are used to establish reliable test limits.
-
How Tech Can Drive In-House API Manufacturing
5/20/2026
Pharmaceutical companies are increasingly moving API production in-house, taking advantage of advanced manufacturing technologies (AMTs) like continuous flow chemistry and automation to drive efficiency, though high costs and cultural shifts remain challenges. By investing in specialized training and strategic facility upgrades, manufacturers can leverage these tools to mitigate supply chain risks, enhance quality, reduce operational complexity, and gain greater control over production timelines.
-
Highly Potent Active Pharmaceutical Ingredients
5/19/2026
Empower safer, faster development of complex therapeutics by partnering with an HPAPI‑focused CDMO that delivers proven containment, rigorous quality, and end‑to‑end expertis
-
In Vivo Manufacturing: When The Body Becomes The Bioreactor
5/15/2026
Breakthrough therapies are reshaping medicine, but manufacturing complexity is holding them back. Discover how rethinking production and delivery could expand reach and improve patient experience.
-
Enhancing Safety In Drug Substance Synthesis: A Smart Approach To Chemical Design
5/6/2026
Discover how safety‑by‑design principles in chemical synthesis help control exothermic reactions, reduce scale‑up risk, and enable safer, more reliable manufacturing of complex drug substances.
-
Gaining An Edge In GLP-1 Production
5/5/2026
The shortage-driven production of GLP-1 drugs of the past few years is giving way to a long-term operation model characterized by digital enablement and supply chain resilience.
-
How Rheology Ensures Effective Quality Control
5/1/2026
Rheology connects formulation science to manufacturing reality. By tracking how drugs flow and respond to stress, teams can prevent batch variability and protect dosage performance.
-
The Stepwise Path Lilly Mapped From Paper To Digital Logbooks
4/30/2026
Eli Lilly and Company started at the front lines, on the shop floor gathering operator input, when switching from paper to digital logbooks.